In laboratory and preclinical models, these peptides have been investigated for their effects on tissue remodeling, angiogenesis, inflammatory modulation, and extracellular matrix activity
A meta-analysis was done which indicates that albiglutide is linked to a higher risk of early-stage DR compared to placebo, while showing a reduced risk of late-stage DR compared to insulin (85) Furthermore, the other six FDA-approved GLP-1RAs do not demonstrate a statistically significant association with DR
Ammonium [NH4]: 0.02% max
Oral GLP-1 approvals and expanded manufacturer programs are likely to shift some demand away from injectables, enhance adherence for patients preferring pills, and introduce new pricing tiers that reflect different distribution models
Lilly has submitted orforglipron to regulators in over 40 countries, with U.S